Fungal endocarditis after transcatheter aortic valve replacement (TAVR): Case report and review of literature.
Candida parapsilosis
Fungal endocarditis
Transcatheter aortic valve inplacement
Transcatheter aortic valve replacement
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
01
07
2018
revised:
15
08
2018
accepted:
25
08
2018
pubmed:
24
9
2018
medline:
4
4
2019
entrez:
24
9
2018
Statut:
ppublish
Résumé
The reported number of transcatheter aortic valve replacement-associated infective endocarditis (TAVR-IE) cases has been increasing worldwide, but information about the incidence and clinical features of fungal TAVR-IE is quite limited. We present a patient who acquired TAVR-IE caused by Candida parapsilosis four month after TAVR, who was successfully treated redo-aortic valve replacement and prolonged antifungal therapy.
Identifiants
pubmed: 30243901
pii: S1341-321X(18)30278-2
doi: 10.1016/j.jiac.2018.08.017
pii:
doi:
Substances chimiques
Antifungal Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
215-217Informations de copyright
Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.